- 1 comment
CYTO-CHIP shows improvement in median OS from 12.1 to 18.8 months.
The therapy could be the first new treatment to improve survival in patients with severe scleroderma in more than four decades.
This is the first randomised controlled trial to investigate the routine use of clinically assisted hydration in cancer patients at the end-of-life.
The launch of the course comes at a time when concerns continue to mount about antimicrobial resistance.
Obesity is a strong risk factor for development of hypertension, diabetes, and more.
Parents of paediatric patients may react more negatively to doctors who communicate uncertainty of diagnosis explicitly.
Obese children are at significantly higher risk.
A small study on the relevance of antidrug antibodies.
A large Veterans’ Affairs study noted modestly elevated risk among unvaccinated patients.
Outcomes similar to that reported in clinical trials.
Topical application can reduce 1-year risk for surgery in patients with a history of keratinocyte carcinomas.
Adjuvant radiation therapy was previously shown to improve locoregional control.
Atopic dermatitis is not associated with the development of cataracts.
The European Junior Doctors has expressed solidarity with Lithuanian doctors
Treatment lacks official recommendation.